Sean A. Mccarthy - Net Worth and Insider Trading
Sean A. Mccarthy Net Worth
The estimated net worth of Sean A. Mccarthy is at least $751,009 dollars as of 2024-11-05. Sean A. Mccarthy is the CEO of CytomX Therapeutics Inc and owns about 751,009 shares of CytomX Therapeutics Inc (CTMX) stock worth over $751,009. Details can be seen in Sean A. Mccarthy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean A. Mccarthy has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sean A. Mccarthy
Sean A. Mccarthy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean A. Mccarthy owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Sean A. Mccarthy’s form 4 insider trades.
Insider Ownership Summary of Sean A. Mccarthy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | director & President and CEO |
Sean A. Mccarthy Latest Holdings Summary
Sean A. Mccarthy currently owns a total of 1 stock. Sean A. Mccarthy owns 751,009 shares of CytomX Therapeutics Inc (CTMX) as of August 20, 2024, with a value of $751,009.
Latest Holdings of Sean A. Mccarthy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | 751,009 | 1.00 | 751,009 |
Holding Weightings of Sean A. Mccarthy
Sean A. Mccarthy Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean A. Mccarthy has made a total of 9 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 13,898 shares on August 20, 2024, which brought Sean A. Mccarthy around $17,095.
Insider Trading History of Sean A. Mccarthy
- 1
Sean A. Mccarthy Trading Performance
Sean A. Mccarthy Ownership Network
Ownership Network List of Sean A. Mccarthy
Ownership Network Relation of Sean A. Mccarthy
Sean A. Mccarthy Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Sean A. Mccarthy is the director & President and CEO of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Sean A. Mccarthy made 4 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 62,273. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 25,172 shares made by Marcia Belvin , a net sale of 19,012 shares made by Lloyd A Rowland , and a net sale of 18,939 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Sean A. Mccarthy Mailing Address
Above is the net worth, insider trading, and ownership report for Sean A. Mccarthy. You might contact Sean A. Mccarthy via mailing address: 343 Oyster Point Blvd., Suite 100, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
